Vertex's Journavx got FDA approval for acute pain but faces adoption challenges: variable efficacy vs opioids, generic competition, and entrenched prescriber habits limit near-term potential ...

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for ...

If you're not happy with the results, please do another search.

A new neural network process has designed wireless chips that can outperform existing ones. This convolutional neural network analyzes the desired chip properties then designs backward.

President Donald Trump said he would soon announce new tariffs on computer chips, repeating a campaign promise that if enacted could have deep impacts on the global tech industry and the ...

Global chip stocks slumped Monday after Chinese artificial-intelligence company DeepSeek said it had developed AI models that nearly matched American rivals despite using inferior chips ...

The Food and Drug Administration is using its most severe notice in a recall of more than 6,000 bags of chips in two states because of “undeclared milk.” By Claire Moses The Food and Drug ...

The rise of Nvidia has spurred renewed investor interest in AI chip startups. One of them, Blaize, founded by former Intel engineers, is set to go public on the Nasdaq in a SPAC deal on Tuesday ...

Frito-Lay has recalled its Lay's Classic Potato Chips in Oregon and Washington state due to undeclared milk that may be in the product that could be fatal if consumed by someone with an allergy or ...